Home » Volumes » Volume 22 Octuber/December 1989 » Citocinas, integrinas e patogenia da malária

Citocinas, integrinas e patogenia da malária

Carlos Eduardo Tosta; Leopoldo L. Santos-Neto

Laboratório de Malária Núcleo de Medicina Tropical e Nutrição Faculdade de Ciências da Saude Universidade de Brasília Brasília DF Brasil

DOI: 10.1590/S0037-86821989000400001


Texto completo disponível apenas em PDF.

Full text available only in PDF format.

 

 

REFERÊNCIAS BIBLIOGRÁFICAS

1. Ballet JJ, Jaureguiberry G, Deloron P, Agrapart M. Stimulation of Thymphocyte-dependent differentiation of activated human B lymphocytes by Plasmodium falciparum supernatants. Journal of Infectious Diseases 155: 1037-1040, 1987.         [ Links ]

2. Bate CAW, Taverne J, Playfair JHL. Malarial parasites induce TNF production by macrophages. Immunology 64: 227-231, 1988.         [ Links ]

3. Bate CAW, Taverne J, Playfair JHL. Soluble malarial antigens are toxic and induce the production of tumour necrosis factor in vivo. Immunology 66:600-605,1989.         [ Links ]

4. Bendtzen K, Svenson M, Jonsson V, Hippe E. Autoantibodies to cytokines – friends or foes? Immunology Today 11: 167-169, 1990.         [ Links ]

5. Beutler BA, Milsark IW, Cerami A. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. Journal of Immunology 135: 3972-3977, 1985.         [ Links ]

6. Clark I A. Suggested importance of monokines in patho-physiology of endotoxin shock and malaria. Klinische Wochenschrift 60: 756-758, 1982.         [ Links ]

7. Clark IA, Chaudhri G. Tumor necrosis factor in malaria-induced abortion. American Journal of Tropical Medicine and Hygiene 39: 246-249, 1988.         [ Links ]

8. Clark IA, Cowden WB, Chaudhri GR. The pleiotropic effects of tumour necrosis factor in malaria. In: Tumor necrosis factor: structure, mechanism of action, role in disease and therapy. Bonavida B, Granger G(eds.). S. Karger, Basel, Switzerland, p. 156-161, 1990.         [ Links ]

9. Ding A, Porten F, Sanchez E, Nathan CF. Downregulation of tumor necrosis factor on macrophages and endothelial cells by microtubule depolymerizing agents. The Journal of Experimental of Medicine 171: 715- 727, 1990.         [ Links ]

10. Endres S, Ghorbani R, Kelley YE, Georgilis K, Lonnemann G, Van Der Meer JWM, Cannon JG, Rogers TS, Klempner MS, Weber PC, Schaefer EJ, Wolff SM, Dinarello, CA. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. The New England Journal of Medicine 320: 265-271, 1989.         [ Links ]

11. Grau GE, Fajardo LF, Piguet PF, Allet B, Lambert PH, Vassalli P. Tumor necrosis factor (cachectin) as an essential mediator in murince cerebral malaria. Science 237: 1210-1212, 1987.         [ Links ]

12. Grau GE, Heremans H, Pighet PF, Pointaire P, Lambert PH, Billiau A, Vassalli P. Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proceedings of The National Academy of Sciences of United States of America 86: 5572.         [ Links ]

13. Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassali, P, Hommel M, Lambert PH. Tumor necrosis factor and disease severity in children with falciparum malaria. The New England Journal of Medicine. 320: 1586-1591, 1989.         [ Links ]

14. Haidaris CG, Haynes JD, Meltzer MS, Allison AC. Serum containing tumor necrosis factor is cytotoxic for the human malaria parasite Plasmodium falciparum. Infection and Immunity 42: 385-393, 1983.         [ Links ]

15. Hoffman SL, Rustama D, Punjabi NH, Surampaet B, Sanjaya B, Dimpudus AJ, McKee KT Jr, Paleologo FP, Campbell JR, Marwoto H, Laughlin L. High-dose dexamethasone in quinine-treated patients with cerebral malaria: a double-blind, placebo-controlled trial. Journal of Infectious Diseases 158: 325-331, 1988.         [ Links ]

16. Hogg N. The leukocyte integrins. Immunology Today 10: 111-114, 1989.         [ Links ]

17. Howard RJ, Gilladoga AD. Molecular studies related to the pathogenesis of cerebral malaria. Blood 74:2603- 2618, 1989.         [ Links ]

18. James K, Interactions between cytokines and amacroglobulin. Immunology Today 11:163-166,1990.         [ Links ]

19. Kremsner PG, Bienzle V. Soluble CD8 antigen in Plasmodium falciparum malaria. Journal of Infectious Diseases 160: 357-358, 1989.         [ Links ]

20. KwiatkowskiD, Cannon JG, Manogue KR, Cerami A, Dinarello CA, Greenwood BM. Tumour necrosis factor production in falciparum malaria and its association with schizont rupture. Clinical and Experimental Immunology 77: 361-366, 1989.         [ Links ]

21. Kunkel SL, Remick DG. Strieter RM, Larrick JW. Mechanisms that regulate the production and effects of tumor necrosis factor-alpha. Critical Reviews in Immunology 9: 93-117, 1989.         [ Links ]

22. Larrick JW. Native interleukin 1 inhibitors. Immunology Today 10: 61-66, 1989.         [ Links ]

23. Mantovani A, Dejana E. Cytokines as communication signals between leukocytes and endothelial cells. Immunology Today 10: 370-375, 1989.         [ Links ]

24. Mller KL, Silverman PH, Kullgren B, Mahlmann LJ. Tumor necrosis factor alpha and the anemia associated with murine malaria. Infection and Immunity 57: 15 42- 1546, 1989.         [ Links ]

25. Ojo-Amaize EA, Vilcek J, Cochrane AH, Nussenzweig RS. Plasmodium berghei sporozoites are mitogenic for murine T cells, induce interferon, and activate natural killer cells. Journal of Immunology 133: 1005-1009, 1984.         [ Links ]

26. Playfair JHL, Taverne J, Bate CAW, Souza JB. The malaria vaccine: anti-parasite or anti-disease? Immunology Today: 11: 25-27. 1990.         [ Links ]

27. Picot S, Peyron F, Vuillez JP, Barbe G, Marsh K, Ambroise-Thomas P. Tumor necrosis factor production by human macrophages stimulated in vitro by Plasmodium falciparum. Infection and Immununity 58: 214- 216, 1990.         [ Links ]

28. Pober JS. Cytokine-mediated activation of vascular endothelium. American Journal of Pathology 133:426- 433, 1988.         [ Links ]

29. Scuderi P. Differential effects of copper and zinc on human peripheral blood monokine cytokine secretion. Cellular Immunology 126: 391-405, 1990.         [ Links ]

30. Scuderi P, Sterling KE, Lam KS, Finley PR, Ryan KJ, Ray CG, Petersen E, Slymen DJ, Salmon SE. Raised serum levels of tumour necrosis factor in parasitic Infections. The Lancet 2: 1364-1365, 1986.         [ Links ]

31. Taverne J, Bate CAW, Playfair JHL. Induction of TNF in vitro as a model for the identification of toxic malaria antigens. Lymphokine Research 8: 317-322, 1989.         [ Links ]

32. Taverne J, Tavemier J, Fiers W, Playfair JHL. Recom binant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro. Clinical and Experimental Immunology. 67: 1-4, 1987.         [ Links ]

33. Tosta CE, Ruiz G, WedderbumN. Effects of lethal and non-lethal malaria on the mononuclear phagocyte system. Revista da Sociedade Brasileira de Medicina Tropical 16: 58-67, 1983.         [ Links ]

34. Zabel P, Wolter DT, Schönharting MM, Schade UF. Oxypentifylline in endotoxaemia. The Lancet 2: 1474- 1477, 1989.         [ Links ]

35. Ward KN, Warrell MJ, Rhodes, J, Looareesuwan S. White NJ. Altered expression of human monocyte Fc receptors in Plasmodium falciparum malaria. Infection and Immunity 44: 623-626, 1984.         [ Links ]

36. Warrell DA, Looareesuwan S, Warrell MJ, Kasemsam P, Intaraprasert R, Bunnag D, Harinasuta T. Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. The New England Journal of Medicine 306: 313-319, 1982.         [ Links ]